0000899243-21-008402.txt : 20210226
0000899243-21-008402.hdr.sgml : 20210226
20210226160303
ACCESSION NUMBER: 0000899243-21-008402
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210224
FILED AS OF DATE: 20210226
DATE AS OF CHANGE: 20210226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barclay Alec
CENTRAL INDEX KEY: 0001734339
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 21688637
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-24
0
0001492674
T2 Biosystems, Inc.
TTOO
0001734339
Barclay Alec
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Operations Officer
Restricted Stock Units
2021-02-24
4
A
0
505464
0.00
A
Common Stock
505464
505464
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The restricted stock units vest in three equal annual installments commencing on February 24, 2022.
/s/ John Sprague, Attorney-in-fact
2021-02-26